Latest autoimmune disease Stories
University of Michigan scientists receive first 1,250 research samples PORTLAND, Ore., Sept.
PsoMe.org is the first to connect kids with psoriatic disease PORTLAND, Ore., July 15 /PRNewswire-USNewswire/ -- Hundreds of children around the country living with psoriasis and psoriatic arthritis have a new resource to help them cope with the psychological and social effects of these illnesses with the launch of the first website for kids with psoriatic disease -- www.PsoMe.org.
AURORA, Colo., July 8 /PRNewswire/ -- Western States Biopharmaceuticals, Inc.
LOS ANGELES, June 2 /PRNewswire/ -- Two new studies suggest that excess levels of a protein associated with inflammation, TNF, may produce cognitive decline. TNF regulates both inflammation and brain function.
HAYWARD, Calif., March 23 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc.
SOUTH SAN FRANCISCO, Calif., March 17 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M.
Milestone Report Addresses Increasing Prevalence, Skyrocketing Costs, New Treatments and Possible Causes of 100+ Diseases WASHINGTON, March 3 /PRNewswire-USNewswire/ -- A groundbreaking new report from the American Autoimmune Related Diseases Association (AARDA), examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to...
A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work.
SOUTH SAN FRANCISCO, Calif., Feb. 16 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that its senior management team will host a conference call, and simultaneous audio webcast, today at 8:30 a.m. EST (5:30 a.m.
SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M.
- A person in a secondary role, specifically the second most important character (after the protagonist).